Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Korro Bio ( (KRRO) ) has shared an announcement.
Korro Bio, Inc. announced that Vineet Agarwal, the Chief Financial Officer, has returned from a temporary medical leave of absence and resumed his duties effective March 27, 2025. The Board of Directors has reappointed him as the principal financial officer. Additionally, Oliver Dolan has been appointed as the principal accounting officer, and he received a stock option award as part of his new role.
More about Korro Bio
YTD Price Performance: -56.70%
Average Trading Volume: 80,655
Technical Sentiment Signal: Buy
Current Market Cap: $191.3M
Learn more about KRRO stock on TipRanks’ Stock Analysis page.